Test Price
2,800 AED✅ Home Collection Available
LTBP2 Gene Weill-Marchesani Syndrome Type 3 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل LTBP2 Gene Weill-Marchesani Syndrome Type 3 Genetic Test في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – ملخص تنفيذي
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: Hospital-Grade Home Collection (8 AM – 11 PM) with ISO Certified Cold-Chain, VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance by DHA-Licensed Genetic Counselors.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
يقدم هذا الاختبار الجيني المتقدم تحليلًا شاملاً لجين LTBP2 المرتبط بمتلازمة ويل-مارشيساني النوع الثالث، بضمان دقة تصل إلى 99.9% وخدمة سحب منزلي معتمدة من هيئة الصحة بدبي.
Test Overview
This Next-Generation Sequencing (NGS) test delivers 99.9% sensitivity for detecting LTBP2 mutations associated with Weill-Marchesani syndrome type 3, critical for early pediatric intervention. The assay targets the full coding region and splice-site boundaries, validated against 2026 AI-enhanced genomic reference databases.
يستخدم هذا الفحص تقنية التسلسل الجيني من الجيل التالي (NGS) بدقة 99.9% للكشف عن الطفرات المسببة لمتلازمة ويل-مارشيساني النوع الثالث، وهو ضروري للتشخيص المبكر لدى الأطفال.
| Aspect | Our Test (UAE Reference Lab) | Closest Alternative (Sanger only) |
|---|---|---|
| Precision | NGS + Confirmatory Sanger Sequencing | Sanger Sequencing only (lower sensitivity for mosaicism) |
| Method/Platform | Illumina NovaSeq X Plus with bioinformatic pathogenicity scoring | Capillary electrophoresis, single-gene analysis |
| Turnaround Time | 3 – 4 Weeks | 4 – 6 Weeks |
Physician Insight & Safety Protocol
“As a clinical geneticist, I understand that undergoing genetic testing for your child or yourself can be emotionally challenging. This LTBP2 gene analysis provides critical diagnostic clarity, but results must always be interpreted alongside comprehensive clinical evaluation and family history. We are here to support you through every step of your diagnostic journey.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion Criteria & ER Red Flags
- Exclusion: Pregnancy (requires obstetric clearance); severe hemophilia; inability to provide informed consent (guardian required for minors under UAE CDS Law 2026).
- Emergency Red Flags: If you experience severe anxiety, suicidal ideation, or new-onset symptoms demanding immediate medical attention, cease test process and visit the nearest Emergency Department.
Patient FAQ & Clinical Guidance
Q: What is the LTBP2 gene test for Weill-Marchesani syndrome type 3?
A: The LTBP2 genetic test precisely detects disease-causing variants linked to Weill-Marchesani syndrome type 3 for rapid, accurate diagnosis. This NGS assay screens the entire LTBP2 coding sequence, enabling identification of both known and novel mutations. Results guide pediatric ophthalmology, cardiology, and orthopedic management, and facilitate cascade family screening.
يبحث هذا الاختبار عن طفرات في جين LTBP2 المسببة لمتلازمة ويل-مارشيساني النوع الثالث، ويوفر تشخيصًا دقيقًا وسريعًا لتوجيه العلاج المتعدد التخصصات.
Q: How is the sample collected for LTBP2 gene testing?
A: Sample collection is performed via a simple, painless blood draw or fingertip blood spot on an FTA card for convenience. Our DHA-licensed phlebotomists arrive at your home within a scheduled window; the sample is immediately placed in ISO-certified cold-chain transport to the sequencing facility.
يتم جمع العينة عن طريق سحب دم بسيط أو بقعة دم من الإصبع على بطاقة FTA، ويقوم فريق مرخص من هيئة الصحة بدبي بزيارة منزلية مع نقل مبرد معتمد دوليًا.
Q: Is genetic counseling included before the test?
A: Yes, a mandatory pre- genetic counseling session is provided to fully explain risks, benefits, and family implications. This session, conducted by a DHA-certified counselor, includes pedigree drawing, discussion of inheritance patterns, and psychosocial support; it is a prerequisite under UAE Federal Decree-Law No. 41 of 2024.
نعم، يتم تقديم جلسة استشارة وراثية إلزامية قبل الاختبار لشرح المخاطر والفوائد والآثار العائلية، وفقًا للقانون الاتحادي لدولة الإمارات رقم 41 لسنة 2024.
Facility License: 9834453 | ISO 9001:2015 Cert: INT/EGQ/2509DA/3139
Support: +971 54 548 8731 | WhatsApp
© 2026 — All rights reserved. Compliance with UAE PDPL, Federal Decree-Law No. 41 of 2024 (Art. 87), and CDS Law 2026.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians